Gerald Quirk
Compliance Officer at SYROS PHARMACEUTICALS, INC.
Net worth: 202 761 $ as of 31/05/2024
Profile
Gerald E.
Quirk is currently the Chief Legal & Compliance Officer at Syros Pharmaceuticals, Inc. He previously held positions such as Co-Chairman-Life Sciences Group at Choate, Hall & Stewart LLP from 2012 to 2015, Managing Corporate Counsel at Genzyme Corp.
from 1998 to 2006, Secretary, VP-Corporate Affairs & General Counsel at Infinity Pharmaceuticals, Inc. from 2009 to 2012, Executive VP-Business Operations & General Counsel at Tokai Pharmaceuticals, Inc. from 2015 to 2016, and Chief Legal & Administrative Officer at Syros Pharmaceuticals, Inc. from 2017 to 2022.
Mr. Quirk received his graduate degree from Harvard University in 1991, his undergraduate degree from Swarthmore College in 1989, and another graduate degree from Northeastern University in 1994.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/03/2024 | 39,757 ( 0.15% ) | 202 761 $ | 31/05/2024 |
Gerald Quirk active positions
| Companies | Position | Start |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Compliance Officer | 01/06/2023 |
Former positions of Gerald Quirk
| Companies | Position | End |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Chief Administrative Officer | 01/03/2022 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | General Counsel | 31/08/2016 |
Choate, Hall & Stewart LLP
 Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/05/2015 |
| INFINITY PHARMACEUTICALS, INC. | Investor Relations Contact | 01/08/2012 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/09/2006 |
Training of Gerald Quirk
| Northeastern University | Graduate Degree |
| Harvard University | Graduate Degree |
| Swarthmore College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
| Palmer & Dodge LLP | Commercial Services |
Choate, Hall & Stewart LLP
Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Choate, Hall & Stewart LLP provides legal services. It offers services in the areas of private equity, technology, intellectual property, mergers & acquisitions, commercial litigation, and insurance & reinsurance litigation. The company was founded in 1899 and is headquartered in Boston, MA. | Commercial Services |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Gerald Quirk
